Brainsway (BWAY)
(Delayed Data from NSDQ)
$8.10 USD
-0.09 (-1.10%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $8.09 -0.01 (-0.12%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth F Momentum C VGM
Income Statements
Fiscal Year end for Brainsway Ltd Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 32 | 27 | 30 | 22 | 23 |
Cost Of Goods | 8 | 7 | 7 | 5 | 5 |
Gross Profit | 23 | 20 | 23 | 17 | 18 |
Selling & Adminstrative & Depr. & Amort Expenses | 28 | 33 | 28 | 22 | 26 |
Income After Depreciation & Amortization | -5 | -13 | -5 | -5 | -8 |
Non-Operating Income | 2 | 0 | -1 | 0 | -1 |
Interest Expense | 1 | 0 | 0 | 0 | 0 |
Pretax Income | -4 | -13 | -6 | -5 | -10 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -4 | -13 | -6 | -5 | -10 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -4 | -13 | -6 | -5 | -10 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -4 | -11 | -3 | -2 | -6 |
Depreciation & Amortization (Cash Flow) | 1 | 2 | 2 | 3 | 3 |
Income After Depreciation & Amortization | -5 | -13 | -5 | -5 | -8 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 16.58 | 16.69 | 15.58 | 11.22 | 20.51 |
Diluted EPS Before Non-Recurring Items | -0.26 | -0.80 | -0.42 | -0.48 | -0.50 |
Diluted Net EPS (GAAP) | -0.26 | -0.80 | -0.42 | -0.48 | -1.00 |
Fiscal Year end for Brainsway Ltd Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 10.01 | 9.10 | 9.03 | 8.30 | 7.83 |
Cost Of Goods | 2.47 | 2.28 | 2.29 | 2.13 | 2.10 |
Gross Profit | 7.54 | 6.81 | 6.74 | 6.17 | 5.73 |
SG&A, R&D, and Dept/Amort Expenses | 6.95 | 6.72 | 6.55 | 6.30 | 7.08 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.59 | 0.09 | 0.19 | -0.13 | -1.35 |
Non-Operating Income | 0.52 | 0.62 | 0.76 | 0.00 | 0.00 |
Interest Expense | 0.40 | 0.43 | 0.99 | 0.04 | 0.14 |
Pretax Income | 0.70 | 0.28 | -0.04 | -0.17 | -1.48 |
Income Taxes | 0.10 | 0.17 | -0.16 | 0.06 | 0.19 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 0.60 | 0.11 | 0.13 | -0.23 | -1.66 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 0.60 | 0.11 | 0.13 | -0.23 | -1.66 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 15.00 | 16.65 | 16.58 | 16.58 | 16.63 |
Diluted EPS Before Non-Recurring Items | 0.04 | 0.01 | 0.01 | -0.01 | -0.10 |
Diluted Net EPS (GAAP) | 0.04 | 0.01 | 0.00 | -0.02 | -0.10 |